Skip to main content

Completed · Belgium · Pharma and biotech

Arcturus Therapeutics acquires myNEO.

Arcturus Therapeutics, based in San Diego, California, completed on 15 October 2026 its acquisition of myNEO, an AI-driven drug discovery company in Ghent, Belgium, agreed on 23 September, through its subsidiary Arcturus Therapeutics Europe B.V. At closing it paid about USD 5.0 million in cash and issued 361,355 shares, with further milestone and collaboration payments capped at USD 20.0 million in total. The deal completed on 15 October 2026.

SigningDay 100

Signing 23 September 2026 · Day 100 on 23 January 2027

Buyer
Arcturus Therapeutics Holdings Inc. ·San Diego, United States
Target
myNEO Therapeutics ·Ghent, Belgium
Type
Acquisition
Announced
23 September 2026
Signed
23 September 2026
Completed
15 October 2026
Value
Not disclosed
People
Not stated in the release
Last checked
6 November 2026

The people side in Belgium

Get the briefing

Deals into Europe lists public facts with their sources, checked every working day by Octagon Professionals International. Corrections go to info@octagon.nl and are made within one working day. How we track deals.

Enabling organisations to operate across borders with clarity, compliance, and trust.

All deals into Europe